Minova Life Science

Minova life sciences - Pharmaceutical company

Trialex-SB 375/ 750/ 1500 Injection

COMPOSITION – Ceftriaxone 500mg/250 mg/1000mg + Sulbactum 250/125/500mg

  • Sulbactam – Ceftriaxone combination provides the unique properties of a broad-spectrum antibiotic with an added advantage of a wide-spectrum Beta-lactamase inhibitor.
  • Provides 94.6% Nigher clinical efficacy against Ceftriaxone resistant strain as compared to Ceftriaxone alone.
  • Shows higher effectivity and bacterial eradication rate in respiratory and urinary tract infections as compared to cefoperazone/sulbactam.
  • Provides higher clinical cured patients in lower RT as compared to Co-Amoxiclav.

Explore other products

Scroll to Top